|Bid||140.60 x 800|
|Ask||143.63 x 800|
|Day's Range||139.01 - 142.60|
|52 Week Range||125.77 - 174.16|
|Beta (5Y Monthly)||1.10|
|PE Ratio (TTM)||8.48|
|Earnings Date||Apr 20, 2022 - Apr 25, 2022|
|Forward Dividend & Yield||2.64 (1.94%)|
|Ex-Dividend Date||Apr 05, 2022|
|1y Target Est||151.86|
We are proud to support the American Heart Association HBCU Scholars. Congratulations to the 50 Scholars who completed this year’s program that concluded with a symposium showcasing their research.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share, payable on July 20, 2022 to shareholders of record of Quest Diagnostics common stock on July 6, 2022.